Alternatively spliced tenascin-C mRNA isoforms in human fetal membranes

Molecular Human Reproduction

Volumn 5, Issue 11, 1999, Pages 1066-1076

  Bell, S C ^a   Pringle, J H ^a   Taylor, D J ^a   Malak, T M ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b EASTBOURNE DISTRICT GENERAL HOSPITAL   (United Kingdom)

Author keywords

Amniochorion; Fetal membranes; mRNA; Splicing; Tenascin C

Indexed keywords

FIBRONECTIN; GELATINASE A; STROMELYSIN; TENASCIN;

ARTICLE; EXON; FETUS; FETUS MEMBRANE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MEMBRANE RUPTURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; RNA TRANSLATION; TISSUE REGENERATION; WOUND;

ALTERNATIVE SPLICING; EXTRAEMBRYONIC MEMBRANES; HUMANS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS; TENASCIN; TUMOR CELLS, CULTURED;

EID: 0032733010     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/5.11.1066     Document Type: Article

References (39)

1. Bell, S.C. and Malak, T.M. (1997) Structural and Cellular Biology of the Fetal Membranes. In Romero, R., Elder, M.G. and Lamont, R.F. (eds), Preterm Labor. Churchill Livingstone, New York and London, pp. 401-428.
2. Borsi, L., Balza, E. Gaggero, B. et al. (1995) The alternative splicing pattern of the tenascin-C pre-mRNA is controlled by the extracellular pH. J. Biol. Chem., 270, 6243-6245.
3. Chiquet-Ehrismann, R. (1990) What distinguishes tenascin from fibronectin? FASEB J., 4, 2598-2604.
4. Chiquet-Ehrismann, R. (1993) Tenascin and other adhesion-modulating proteins in cancer. Semin. Cancer Biol., 4, 301-310.
5. Chomczynski, P. and Sacchi, N. (1987) Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
6. Chung, C.Y. and Erickson, H.P. (1994) Cell, surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J. Cell. Biol., 126, 539-548.
7. Chung, C.Y., Murphy-Ullrich, J.E. and Erickson. H.P. (1996) Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor annexin II. Mol. Cell. Biol., 7, 883-892.
8. Crossin, K.L. (1996) Tenascin : a multifunctional extracellular matrix protein with a restricted distribution in development and disease. J. Cell. Biochem., 61, 592-598.
9. Erickson, H.P. (1993) Tenascin-C, tenascin-R and tenascin-X : a family of talented proteins in search of functions. Curr. Opin. Cell. Biol., 5, 869-876.
10. French, J.I. and McGregor, J. A. (1996) The pathobiology of premature rupture of membranes. Sem. Perinatol., 20, 344-368.
11. Gherzi, R., Carnemolla, B., Siri, A. et al. (1995) Human tenascin gene. Structure of the 5′-region, identification, and characterization of the transcription regulatory sequences. J. Biol. Chem., 270, 3429-3434.
12. Gundersen, D., Tran-Thang, C., Sordat, B. et al. (1997) Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering. J. Immunol., 158, 1051-1060.
13. Gulcher J.R., Nies, D.E., Alexakos, M.J. et al. (1991) Structure of the human hexabrachion (tenascin) gene. Proc. Natl. Acad. Sci. USA, 88, 9438-9442.
14. Imai, K., Kusakabe, M.J., Sakakura, T. et al. (1994) Susceptibility of tenascin to degradation by matrix metalloproteinases and serine proteinases. FEBS Letts., 352, 216.
15. Kelly, T. (1995) The pathophysiology of premature rupture of the membranes. Curr. Opin. Obstet. Gynaecol., 7, 140-145.
16. Mackie, E.J., Halfter, W. and Liverani, W. (1988) Induction of tenascin in healing wounds. J. Cell. Biol., 107, 2757-2767.
17. Malak, T.M. and Bell, S.C. (1993) The structural characteristics of spontaneously ruptured fetal membranes: their relationship to membrane rupture and parturition. Com. Rev. Obstet. Gynaecol., 5, 117-123.
18. Malak, T.M. and Bell, S.C. (1994) Structural characteristics of term human fetal membranes (amniochorion and decidua): a novel zone of extreme morphological alteration within the rupture site. Br. J. Obstet. Gynaecol., 101, 375-386.
19. Malak, T.M. and Bell, S.C. (1996) Fetal membranes structure and prelabour rupture. Fetal Maternal Med. Rev., 8, 143-164.
20. Mighell, A.J., Thompson, J., Hume, W.J. et al. (1997) Human tenascin-C: Identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae. Int. J. Cancer, 72, 236-240.
21. McLaren, J., Taylor, D.J. and Bell, S.C. (1999) Increased pro-matrix metalloproteinase-9 in term fetal membranes overlying the cervix prior to labour: implications for membrane remodelling and rupture. Am. J. Obstet. Gynecol. in press.
22. McParland, P.C. and Bell, S.C. (1998) Localization of the extracellular matrix protein tenascin-C at the materno-fetal interface during pregnancy. Br. J. Obstet. Gynaecol., 105 (Suppl. 17), 211.
23. McParland, P.C., Pringle, J.H. and Bell, S.C. (1998) Tenascin and the fetal membrane wound hypothesis - programming for fetal membrane rupture? Br. J. Obstet. Gynaecol., 105, 1223-1224.
24. McParland, P.C., Taylor, D.J. and Bell, S.C. (1999) Myofibroblast differentiation in the connective tissues of the amnion and chorion of term human fetal membranes : implications for fetal membrane rupture and labour. Placenta, in press.
25. Murphy-Ullrich, J.E., Lightner, V.A., Aukhil, I. et al. (1991) Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J. Cell. Biol., 115, 1127-1136.
26. Nies, D.E., Hemesath, T.J., Kim, J. H. et al. (1991) The complete cDNA sequence of human hexabrachion (Tenascin) A multidomain protein containing unique epidermal growth factor repeats. J. Biol. Chem., 266, 2818-2823.
27. Parry, S. and Strauss, J.F. (1998) Premature rupture of the fetal membranes. N. Engl. J. Med., 338, 663-670.
28. Saghizadeh, M., Khin, H.L., Bourdan, M.A. et al. (1998) Novel splice variants of human tenascin-C in normal and bullous keratopathy corneas. Cornea, 17, 326-332.
29. Siri, A., Carnemolla, B., Saginati, M. et al. (1991) Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognised by two monoclonal antibodies. Nucleic Acids Res., 19, 525-531.
30. Siri, A., Knauper, V., Veirana, N. et al. (1995) Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J. Biol. Chem., 270, 8650-8654.
31. Southern, E.M. (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol., 98, 503-509.
32. Sriramarao, P. and Bourdon, M.A. (1993) A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices. Nucleic Acids Res., 21, 163-168.
33. Stetler-Stevenson, W.G., Aznavoorian, S. and Liotta, L.A. (1993) Tumor cell interactions with extracellular matrix during invasion and metastasis. Ann. Rev. Cell. Biol., 9, 541-573.
34. Tremble, P., Chiquet-Ehrismann, R. and Werb. Z. (1994) The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol. Cell. Biol., 5, 439-453.
35. Vadillo-Ortega, F., Gonzalez-Avila, G., Furth, E.E. et al. (1995) 92-kd Type IV collagenase (Matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am. J. Pathol., 146, 148-156.
36. Vollmer, G., Tan, M.I. Wunsche, W. and Frank, K. (1997) Expression of tenascin-C by human endometrial adenocarcinoma and stromal cells : heterogeneity of splice variants and induction by TGF-beta. Biochem. Cell. Biol., 75, 759-769.
37. Vrucinic-Filippi, N. and Chiquet-Ehrismann, R. (1993) Tenascin function and regulation of expression. S.E.B. Symp., 47, 155-162.
38. Whitby, D.J., Longaker, M.T., Harrison, M.R. et al. (1991) Rapid epithehalisation of fetal wounds is associated with the early deposition of tenascin. J. Cell. Sci., 99, 583-586.
39. Wilson, K.E., Langdon, S.P., Lessells, A.M. and Miller, W.R. (1996) Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours. Br. J. Cancer, 74, 999-1004.